SELLAS Life Sciences Group, Inc. (SLS)
14.32
-1.14
(-7.34%)
USD |
NASDAQ |
Aug 24, 16:00
14.32
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Assets (Quarterly) : 145.38M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 145.38M |
| March 31, 2026 | 114.18M |
| December 31, 2025 | 78.34M |
| September 30, 2025 | 51.56M |
| June 30, 2025 | 32.30M |
| March 31, 2025 | 34.96M |
| December 31, 2024 | 19.63M |
| September 30, 2024 | 26.50M |
| June 30, 2024 | 15.12M |
| March 31, 2024 | 24.43M |
| December 31, 2023 | 6.403M |
| September 30, 2023 | 8.086M |
| June 30, 2023 | 18.57M |
| March 31, 2023 | 29.10M |
| December 31, 2022 | 21.13M |
| September 30, 2022 | 26.00M |
| June 30, 2022 | 32.21M |
| March 31, 2022 | 21.43M |
| December 31, 2021 | 26.43M |
| September 30, 2021 | 37.95M |
| June 30, 2021 | 43.62M |
| March 31, 2021 | 40.58M |
| December 31, 2020 | 47.20M |
| September 30, 2020 | 18.51M |
| June 30, 2020 | 14.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.03M |
| December 31, 2019 | 16.61M |
| September 30, 2019 | 21.48M |
| June 30, 2019 | 25.03M |
| March 31, 2019 | 14.93M |
| December 31, 2018 | 18.34M |
| September 30, 2018 | 38.47M |
| June 30, 2018 | 31.97M |
| March 31, 2018 | 33.48M |
| December 31, 2017 | 33.53M |
| September 30, 2017 | 49.60M |
| June 30, 2017 | 60.55M |
| March 31, 2017 | 70.33M |
| December 31, 2016 | 65.81M |
| September 30, 2016 | 72.85M |
| June 30, 2016 | 73.78M |
| March 31, 2016 | 66.36M |
| December 31, 2015 | 82.14M |
| September 30, 2015 | 82.67M |
| June 30, 2015 | 101.97M |
| March 31, 2015 | 108.61M |
| December 31, 2014 | 80.49M |
| September 30, 2014 | 79.49M |
| June 30, 2014 | 80.28M |
| March 31, 2014 | 92.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Savara, Inc. | 192.14M |
| Lite Strategy, Inc. | 57.79M |
| AbbVie, Inc. | 135.12B |
| Marker Therapeutics, Inc. | 14.59M |
| Rezolute, Inc. | 125.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.726M |
| Shareholders Equity (Quarterly) | 137.66M |
| Debt to Equity Ratio | 0.0054 |
| Current Ratio | 18.83 |
| Net Debt Paydown Yield | 0.00% |